Proteomic analysis revealed 105 common proteins altered in ECC-1 and RL95-2 cells upon DEAB treatment, suggesting ALDH18A1, SdhA, and UBAP2L as potential markers for endometrial cancer. The gene discussed is ALDH18A1; the disease is endometrial cancer.